Lymphoma Topics

The On-Topic Netowork

Lymphoma > Corticosteroids


Corticosteroids
Corticosteroids
Corticosteroids
Corticosteroids
Corticosteroids

The following information is about Corticosteroids.

Corticosteroids Defined

Hormones that have antitumor activity in lymphomas and lymphoid leukemias; in addition, corticosteroids (steroids) may be used for hon-none replacement and for the management of some of the complications of cancer and its treatment.

This definition is in context to Lymphoma. See more contextual defintions for Corticosteroids.


Navigation: [ 1 2 3 Next ]

Children left behind on health care

Published October 11, 2008, 7:37 pm, Atlanta Journal-Constitution

The Hulse family staggered into North Georgia in January with $630 and hope for better times. Gary Hulse had lost his plumbing job in Arkansas, and the family had lost their home there.

Full Story


Doctors' Groups Collaborate on Care for Heart Patients

Published October 10, 2008, 12:30 pm, MedicineNet.com

Title: Doctors' Groups Collaborate on Care for Heart Patients Category: Health News Created: 10/10/2008 2:00:00 AM Last Editorial Review: 10/10/2008

Full Story


ROTATEQ(R) Receives WHO Pre-qualification

Published October 10, 2008, 5:30 am, Business Wire via Yahoo! Finance

WHITEHOUSE STATION, N.J.----ROTATEQ® , the pentavalent rotavirus vaccine from Merck & Co., Inc., that helps prevent rotavirus gastroenteritis in infants and children, has been awarded pre-qualification status by the World Health Organization .

Full Story


Basilea's alitretinoin receives marketing approval in Germany

Published October 10, 2008, 4:49 am, PharmaBiz

Basilea Pharmaceutica Ltd. announces that Toctino (alitretinoin), a new once-daily oral treatment for adults with severe chronic hand eczema (CHE) unresponsive to potent topical corticosteroids, has been approved by the German health authority "Bundesinstitut für Arzneimittel und Medizinprodukte" (BfArM).

Full Story


Sirion Therapeutics Launches Durezol For Postoperative Ocular Inflammation And Pain

Published October 10, 2008, 3:08 am, PharmaceuticalOnline

Sirion Therapeutics, Inc., announced recently that Durezol (difluprednate ophthalmic emulsion) 0.05% is now commercially available. Durezol, which was approved by the U.S. Food and Drug Administration in June 2008, is a topical ophthalmic corticosteroid indicated for the treatment of inflammation and pain associated with ocular surgery.

Full Story


Effective, Low-Cost Ways To Get Rid Of A Stuffy Problem -- Sinusitis

Published October 9, 2008, 3:08 am, Medical News Today

Home remedies often can reduce problematic sinus symptoms, according to the October issue of Mayo Clinic Women's HealthSource. Symptoms, including nasal congestion, facial pain, headache and fatigue, are common. Annually, doctors report about 32 million cases of chronic sinusitis -- when patients' symptoms last 12 consecutive weeks.

Full Story


Early Data Show Potential For Imatinib Mesylate Tablets To Treat Life-Threatening Form Of Pulmonary Artery Disease

Published October 9, 2008, 3:06 am, Medical News Today

An early proof-of-concept study presented shows promising results for imatinib mesylate in the treatment of pulmonary arterial hypertension (PAH), a severe, incurable blood vessel disorder.

Full Story


October 2008 Mayo Clinic Women's HealthSource Highlights Sinusitis, Short Naps and Stress

Published October 8, 2008, 7:49 am, PR Newswire via Yahoo! News

Here are highlights from the October issue of Mayo Clinic Women's HealthSource. You may cite this publication as often as you wish. Mayo Clinic Women's HealthSource attribution is required. Reprinting is allowed for a fee. Include the following subscription information as your editorial policies permit: Visit www.bookstore.mayoclinic.com or call toll-free for subscription information, ...

Full Story


Effective, Low-Cost Ways to Get Rid of A Stuffy Problem -- Sinusitis

Published October 8, 2008, 7:21 am, Newswise

Home remedies often can reduce problematic sinus symptoms, according to the October issue of Mayo Clinic Women's HealthSource.

Full Story


CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation In Crohn's Disease Patients

Published October 8, 2008, 3:07 am, Medical News Today

Data from two studies presented this week by UCB at the American College of Gastroenterology (ACG) Annual Meeting demonstrate that CIMZIA(R) (certolizumab pegol) - the only PEGylated anti-TNF alpha (Tumor Necrosis Factor alpha) - provides sustained improvement in symptoms with stable dosing for adult patients suffering from moderate to severe Crohn's disease (CD).

Full Story


Navigation: [ 1 2 3 Next ]

Are you looking for additional Lymphoma > Corticosteroids news? Try our new "Corticosteroids News Focus" area.

Off-site Corticosteroids Links, User Submitted

The following links have been collected through user bookmark submission in the Corticosteroids category. Please note, because these resources are off-site we cannot guarantee the accuracy or quality of any information.

Mon Aug 11

  • The Next Step in Moderate Asthma: Patients in the moderate group who are still symptomatic with reduced activity and flow rates despite the combination of a long-acting B2-adrenergic agonist and medium doses of an inhaled...

Wed Jul 23

Sun Jul 20

Mon Jul 14

Mon Apr 14

Fri Mar 28

Thu Feb 28

Tue Dec 18

Thu Dec 13

If you would like to find additional social bookmark based links on the topic of we recommend the Open Tag Directory > Corticosteroids. If you would like to find related tags we recommend Tag Patterns > Corticosteroids

Off-site Corticosteroids Research Links

If you still need additional information on Corticosteroids then we suggest the following off-site resources. Please note, because these resources are off-site we cannot guarantee the accuracy or quality of any information.

Lymphoma

If you know the Lymphoma Term Name use the links below to quickly jump to your desired focus.



Bookmark Us

The On Topic Network

This website is part of The On Topic Network.

Thank You

Lymphoma.On-Topic.net was developed by Odin Metatech, Inc and runs on the Odin Assemble platform.

Best Viewed With

License

Creative Commons License This work is licensed under Creative Commons.




Powered by Odin Assemble 2.5a